FDA.reportPublic FDA data

Avandamet 4/500 MG Oral Tablet

RxCUI
861818
RxNorm name
Avandamet 4/500 MG Oral Tablet
Display name
Avandamet 4/500 MG Oral Tablet
Full name
Avandamet 4/500 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0789dc6b-db34-44a6-8a5d-fdcc8e4ce8fdmetformin hydrochloride 500 MG / rosiglitazone 4 MG Oral Tablet [Avandamet] [SBD] · Avandamet 4/500 MG Oral Tablet [SY]26These highlights do not include all the information needed to use AVANDAMET safely and effectively. See full prescribing information for AVANDAMET. AVANDAMET (rosiglitazone maleate and metformin hydrochloride) Tablets Initial U.S. Approval: 200220120830